Pfizer lobbied on pharmaceutical issues

Pfizer Inc., the world's largest drug maker, spent $13.8 million to lobby the federal government in 2007.

The company lobbied on various appropriations bills, as well as on pharmaceutical counterfeiting and imports, Medicare drug pricing, generic drug settlements, veterans' health care issues, electronic prescribing, foreign tax treaties, research and development tax credit extensions and more, according to a disclosure form posted online Feb. 14 by the Senate's public records office.
The New York-based company, maker of the top-selling cholesterol drug Lipitor, spent nearly $6.6 million in the second half of 2007 to lobby on those issues.

Besides Congress, Pfizer lobbied the departments of Defense, Veterans Affairs, Health and Human Services, Commerce and State, as well as the Patent and Trademark Office, White House, Food and Drug Administration and the U.S. Trade Representative's office.

Among those lobbying on the company's behalf were: Anthony Principi, former U.S. Secretary for Veterans Affairs; Lisa Coen, a former director for the National Security Council; John Halliwell, former chief of staff to Rep. Ed Whitfield, R-Ky.; Stephanie Henning, formerly of the House Ways and Means Committee; and Kimberly Pinter, former tax counsel with the U.S. Senate.

Lobbyists are required to disclose activities that could influence members of the executive and legislative branches, under a federal law enacted in 1995.

Source :

0 التعليقات:

  ©Template by Dicas Blogger.